Richard Keen, Baron Keen of Elie

Keen in 2015 Richard Sanderson Keen, Baron Keen of Elie (born 29 March 1954) is a British lawyer and Conservative Party politician. He was Advocate General for Scotland from May 2015 until his resignation on 16 September 2020. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'Richard Keen', query time: 0.02s Refine Results
  1. 1
    The prevalence of musculoskeletal pain and therapy needs in adults with Osteogenesis Imperfecta (OI) a cross-sectional analysis

    The prevalence of musculoskeletal pain and therapy needs in adults with Osteogenesis Imperfecta (OI) a cross-sectional analysis by Sophie Barlow, Lucy Dove, Anju Jaggi, Richard Keen, Judith Bubbear

    Published 2022-05-01
    Get full text
    Article
  2. 2
    Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva

    Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva by Robert J. Pignolo, Mona Al Mukaddam, Geneviève Baujat, Matthew A. Brown, Carmen De Cunto, Edward C. Hsiao, Richard Keen, Kim-Hanh Le Quan Sang, Donna R. Grogan, Rose Marino, Andrew R. Strahs, Frederick S. Kaplan

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment

    Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment by Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands

    Published 2023-02-01
    Get full text
    Article
  4. 4
    Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description

    Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description by Maria Luisa Brandi, Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M. Boot, Karine Briot, Carmen de Lucas Collantes, Francesco Emma, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, Outi Mӓkitie, Ola Nilsson, Dirk Schnabel, Liana Tripto-Shkolnik, M. Carola Zillikens, Jonathan Liu, Alina Tudor, M. Zulf Mughal

    Published 2022-09-01
    Get full text
    Article
  5. 5
    The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data

    The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data by Gema Ariceta, Signe Sparre Beck-Nielsen, Annemieke M. Boot, Maria Luisa Brandi, Karine Briot, Carmen de Lucas Collantes, Francesco Emma, Sandro Giannini, Dieter Haffner, Richard Keen, Elena Levtchenko, Outi Mӓkitie, M. Zulf Mughal, Ola Nilsson, Dirk Schnabel, Liana Tripto-Shkolnik, Jonathan Liu, Angela Williams, Sue Wood, M. Carola Zillikens

    Published 2023-09-01
    Get full text
    Article

Search Tools: